LabQ Clinical Exercise 8: Hematology: ARGATROBAN, BIVALIRUDIN, DABIGATRAN, AND OTHER NOVEL ANTICOAGULANTS IN THE COAGULATION LABORATORY

This is an online activity in Hematology that offers 2.0 continuing education (CMLE) credit that can be used to fulfill CMP requirements.

Write a Review

List Price: $20.00
Member Price: $15.00

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Join

Item Details:

ELIZABETH M. VAN COTT, MD

MASSACHUSETTS GENERAL HOSPITAL

Boston, Massachusetts

Primary Audience: Phlebotomists, Laboratory Technologists, Laboratory Directors

Secondary Audience: Pathologists, Clinical Scientists (Includes all sub-specialty areas), Students, Pathologist Assistants,...

ELIZABETH M. VAN COTT, MD

MASSACHUSETTS GENERAL HOSPITAL

Boston, Massachusetts

Primary Audience: Phlebotomists, Laboratory Technologists, Laboratory Directors

Secondary Audience: Pathologists, Clinical Scientists (Includes all sub-specialty areas), Students, Pathologist Assistants, Residents, and Students

Upon completion of this activity, you will be able to:

· discuss the new anticoagulants and which factor each inhibits to produce anticoagulant effects;

· describe how the laboratory can determine if these anticoagulants are present in a blood specimen;

· describe the hypercoagulation tests that are adversely affected by the new anticoagulants; and

explain how to monitor warfarin while transitioning from argatroban (or dabigatran or bivalirudin) to warfarin.

View More View Less

First Name *
Last Name *
Email *
Customer ID

Name *
Country Code *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

LabQ Clinical Exercise 8: Hematology: ARGATROBAN, BIVALIRUDIN, DABIGATRAN, AND OTHER NOVEL ANTICOAGULANTS IN THE COAGULATION LABORATORY

Item Details:

Bought This Bought That ...